Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 12Multiple Myeloma 9Lymphoma 8Breast Neoplasms 8Lymphoma, Non-Hodgkin 7Hodgkin Disease 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neuroblastoma 6Lymphoma, Large B-Cell, Diffuse 4Central Nervous System Neoplasms 4Burkitt Lymphoma 4Sarcoma 3Medulloblastoma 3Leukemia 3Brain Neoplasms 3Anemia, Refractory, with Excess of Blasts 3Wilms Tumor 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Retinoblastoma 2Recurrence 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms, Plasma Cell 2Malignant mesenchymal tumor 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Follicular 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2

Interventions

Watchful Waiting 1Vincristine 1Radiotherapy, Conformal 1Radiotherapy 1Platinum 1Observation 1Methylphenidate 1Mesna 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Fentanyl 1Etoposide 1Donepezil 1Cyclophosphamide 1Cisplatin 1Carboplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Ependymoma × Granulocyte Colony-Stimulating Factor × Clear all
NCT01096368 2026-04-30

Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

Children's Oncology Group

Phase 3 Completed
479 enrolled 24 charts

Ependymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡